Literature DB >> 35177887

A Practical Approach for Primary Care Practitioners to Evaluate and Manage Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia.

Bruce W Sperry1, Stephen Summers1,2, Darshan Patel3,4, Morgan Garcia1, Catherine Bandeko1.   

Abstract

BACKGROUND: Benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) are common clinical encounters for most primary care practitioners (PCPs). More than 50% of men aged > 50 years will develop significant lower urinary tract symptoms. Managing these symptoms can be complicated and requires an informed discussion between the PCP and the patient. This article provides a comprehensive review for PCPs regarding the evaluation and management of LUTS in men and when to consider a urology referral. OBSERVATIONS: Over the past 3 decades, medications have become the most common BPH and LUTS therapy, but recently, newer minimally invasive surgeries have challenged this paradigm. PCPs are in a unique position to help many patients who present with early stage LUTS.
CONCLUSIONS: A clear understanding of the available treatment options will help PCPs counsel patients appropriately about lifestyle modification, medications, and surgical treatment options for their symptoms.
Copyright © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2021        PMID: 35177887      PMCID: PMC8843009          DOI: 10.12788/fp.0197

Source DB:  PubMed          Journal:  Fed Pract        ISSN: 1078-4497


  46 in total

1.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

2.  Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia.

Authors:  Yinghui Duan; James J Grady; Peter C Albertsen; Z Helen Wu
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-01-09       Impact factor: 2.890

Review 3.  BPH: epidemiology and comorbidities.

Authors:  Kevin T McVary
Journal:  Am J Manag Care       Date:  2006-04       Impact factor: 2.229

Review 4.  Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review.

Authors:  Landon Trost; Theodore R Saitz; Wayne J G Hellstrom
Journal:  Sex Med Rev       Date:  2015-10-21

5.  Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study.

Authors:  Kevin T McVary; Tyson Rogers; Claus G Roehrborn
Journal:  Urology       Date:  2019-01-21       Impact factor: 2.649

Review 6.  An evidence-based strategy for the conservative management of the male patient with incontinence.

Authors:  Diane K Newman; Thomas Guzzo; David Lee; Ravishankar Jayadevappa
Journal:  Curr Opin Urol       Date:  2014-11       Impact factor: 2.309

7.  Benign prostatic hyperplasia: an overview.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2005

8.  Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study.

Authors:  Christian Gratzke; Neil Barber; Mark J Speakman; Richard Berges; Ulrich Wetterauer; Damien Greene; Karl-Dietrich Sievert; Christopher R Chapple; Jacob M Patterson; Lasse Fahrenkrug; Martin Schoenthaler; Jens Sonksen
Journal:  BJU Int       Date:  2016-12-21       Impact factor: 5.588

9.  Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study.

Authors:  Luca Cindolo; Luisella Pirozzi; Caterina Fanizza; Marilena Romero; Andrea Tubaro; Riccardo Autorino; Cosimo De Nunzio; Luigi Schips
Journal:  Eur Urol       Date:  2014-11-20       Impact factor: 20.096

10.  The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

Authors:  John D McConnell; Claus G Roehrborn; Oliver M Bautista; Gerald L Andriole; Christopher M Dixon; John W Kusek; Herbert Lepor; Kevin T McVary; Leroy M Nyberg; Harry S Clarke; E David Crawford; Ananias Diokno; John P Foley; Harris E Foster; Stephen C Jacobs; Steven A Kaplan; Karl J Kreder; Michael M Lieber; M Scott Lucia; Gary J Miller; Mani Menon; Douglas F Milam; Joe W Ramsdell; Noah S Schenkman; Kevin M Slawin; Joseph A Smith
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.